Ruo-yi Xue
Chongqing, 400038, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
RBD-displaying OMV nanovaccine boosts immunity against SARS-CoV-2.
Journal: Journal of nanobiotechnology
Published: November 13, 2024
pGM-CSF as an adjuvant in DNA vaccination against SARS-CoV-2.
Journal: International journal of biological macromolecules
Published: January 16, 2024
Synthetic Self-Adjuvanted Lipopeptide Vaccines Conferred Protection against Helicobacter pylori Infection.
Journal: Advanced healthcare materials
Published: February 09, 2023
A novel indolylbenzoquinone compound HL-J6 suppresses biofilm formation and α-toxin secretion in methicillin-resistant Staphylococcus aureus.
Journal: International journal of antimicrobial agents
Published: February 01, 2023
A "Plug-and-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-binding Domain.
Journal: Journal of visualized experiments : JoVE
Published: August 08, 2022
Novel Synthetic Lipopeptides as Potential Mucosal Adjuvants Enhanced SARS-CoV-2 rRBD-Induced Immune Response.
Journal: Frontiers in immunology
Published: December 11, 2021
HtrA family proteases of bacterial pathogens: pros and cons for their therapeutic use.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: April 21, 2020
Synthetic Lipopeptide Enhances Protective Immunity Against Helicobacter pylori Infection.
Journal: Frontiers in immunology
Published: February 22, 2019
The mucosal adjuvant effect of plant polysaccharides for induction of protective immunity against Helicobacter pylori infection.
Journal: Vaccine
Published: September 13, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026